Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v9-FR | Version v6-FR | |
---|---|---|
Language | French | French |
Date Updated | 2022-09-14 | 2022-05-02 |
Drug Identification Number | 02485680 | 02485680 |
Brand name | NOREPINEPHRINE BITARTRATE INJECTION USP | NOREPINEPHRINE BITARTRATE INJECTION USP |
Common or Proper name | Norepinephrine Bitartrate Injection | Norepinephrine Bitartrate Injection |
Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
Ingredients | NOREPINEPHRINE | NOREPINEPHRINE |
Strength(s) | 1MG | 1MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 1mg/ml 4 ml ampoule, pack of ten ampoules | 1mg/ml 4 ml ampoule, pack of ten ampoules |
ATC code | C01CA | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. | Other (Please describe in comments) |
Anticipated start date | 2022-05-02 | 2022-05-02 |
Actual start date | 2022-05-02 | 2022-05-02 |
Estimated end date | Unknown | 2022-09-02 |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Reduction in current demand. | |
Health Canada comments |